Concepedia

Collin M. Spencer

CM

22

Publications

1.7K

Citations

19

H-Index

1998

Active since

Affiliations

University of California, San Francisco(Current)

Stanford University

Australian Regenerative Medicine Institute

San Francisco General Hospital

Monash University

Collin M. Spencer is an author at University of California, San Francisco specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1998–2024

22

Publications

22

Aquaporin 4‐specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize <i>Clostridium</i> ABC transporter

Michel Varrin‐Doyer, Collin M. Spencer, Ulf Schulze‐Topphoff et al. · Annals of Neurology · 2012 · 335 citations · Full text

Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2

Ulf Schulze‐Topphoff, Michel Varrin‐Doyer, Kara Pekarek et al. · Proceedings of the National Academy of Sciences · 2016 · 293 citations · Full text

Reduction of CD8 <sup>+</sup> T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate

Collin M. Spencer, Elizabeth Crabtree‐Hartman, Klaus Lehmann‐Horn et al. · Neurology Neuroimmunology & Neuroinflammation · 2015 · 185 citations · Full text

Gut microbiome analysis in neuromyelitis optica reveals overabundance of <i>Clostridium perfringens</i>

Bruce Cree, Collin M. Spencer, Michel Varrin‐Doyer et al. · Annals of Neurology · 2016 · 141 citations · Full text

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls

Helen Tremlett, Douglas Fadrosh, Ali A. Faruqi et al. · BMC Neurology · 2016 · 116 citations · Full text

Rows per page

1–5 of 22